Chronic Obstructive Pulmonary Disease, Emphysema or COPD
Conditions
Keywords
Ultrasound, Diaphragm, Endobronchial valves, Endobronchial Lung Volume Reduction
Brief summary
In some patients with chronic obstructive pulmonary disease (COPD) the breathlessness is caused by hyperinflation of the lungs. This causes difficulty breathing air out and makes it harder to breath in new air and limits the movement of the diaphram. The diaphragm is the muscle used for breathing between the chest and the stomach. Some of these patients can receive treatment with endobronchial valves, where one-ways are inserted into the bronchial system the let out some of the excess air, and thereby relieve breathlessness. The goal of this observational study is to investigate the effect of endobronchial valves on the mobility of the diaphragm in patients with chronic obstructive pulmonary disease. The main questions it aims to answer are: * If the movement of the diaphragm improves after treatment with endobronchial valves. * If there is a link between improvement of diaphragm function and improvement of symptoms, lung function and physical ability. * If ultrasound scan immediately after the treatment will predict which patients will benefit from the treatment. Participants will undergo ultrasound before, 1 day after and 90 days after the procedure, and lung function examinations from their already planned control visits will be collected.
Detailed description
When emphysema is present in COPD-patients, the impaired expiratory ventilation causes lung hyperinflation. This results in a change in the respiratory mechanisms of the thorax and thereby impairment of the movement capacity of the muscles. The most important respiratory muscle, the diaphragm, is caudally displaced and flattened, hence, the capacity and mobility of the muscle decreases. Some patients with COPD fulfill the criteria for treatment with endobronchial valves (EBV) where one-way valves can be inserted in the bronchial system. The mechanism behind the effect of EBV is believed to be formation of an atelectasis of the designated lobe and thereby reduction of hyperinflation and hence reduction of symptoms and increase in pulmonary function In this study the aim is to assess: 1. If the movement of the diaphragm improves after insertion of endobronchial valves in patients with severe emphysema. 2. If there is a correlation between improvement of diaphragm function and improvement of symptoms, lung function examinations and physical ability after insertion of endobronchial valves. 3. If immediate post-procedural ultrasound evaluation of diaphragm function predicts the development of atelectasis and hence clinical outcome
Interventions
None listed
Sponsors
Aarhus University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients selected to receive treatment with endobronchial valves 2. Signed informed consent
Exclusion criteria
1. Neuromuscular disease interfering with diaphragm function 2. Pleural effusion at time of preoperative or 90-days postoperative ultrasound
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diaphragm mobility | Before the procedure, 1 day after the procedure and 90 days after the procedure | The area method\[13\] will be used for assessment of diaphragm movement, using a curvilinear probe (2-6 MHz). Measurements will be performed during tidal respiration, deep respiration, sniff excursion and constant flow with constant volume, using test flute with bag of air attached. |
| Diaphragm Thickening | Before the procedure, 1 day after the procedure and 90 days after the procedure | Thickness and thickening ratio: The thickness and thickening ratio will be evaluated in B-mode using the linear probe, though lateral intercostal view during tidal respiration. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Forced expiratory volume in 1 second % of expected | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
| Forced vital capacity in litres | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
| Forced vital capacity in % of expected | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
| Total lung volume in % of expected | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
| Medical Research Council (MRC) Dyspnoea Scale | Before, one day and 90 days after the procedure | Medical Research Council (MRC) score will be used for symptom burden assessment |
| diffusion capacity in % of expected | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
| 6 Minute walking test | Before and 90 days after the procedure | Patients will undergo 6 minutes walking test as a part of the independent preoperative and postoperative assessments |
| Rate of atelectasis on Lung X-ray | Before, one day and 90 days after the procedure | Patients will receive x ray of the lungs as a part of the independent preoperative and postoperative assessments |
| COPD Assessment Test (CAT) Score | Before, one day and 90 days after the procedure | CAT score will be used for symptom burden assessment |
| Residual volume in % of expected | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
| Forced expiratory volume in 1 second in litres | Before and 90 days after the procedure | Patients will undergo lung function examinations as a part of the independent preoperative and postoperative assessments |
Countries
Denmark
Outcome results
None listed